Compound 1 contains a rigid chelating ligand and compounds 2 and 3 contain monodentate dangling pyridine ligands. The rigid chelating ligand can efficiently change the phonon induced magnetization relaxation processes at low temperatures.
The objective of this research is to obtain uniform vacuum-deposition triclinic phase II crystal of titanyl phthalocyanine (α-TiOPc) films from various TiOPc crystal forms. The crystal structure and morphology of vacuum-deposited TiOPc films can be manipulated by deposition rate and substrate temperature. Crystal structure was determined by X-ray diffraction (XRD). Thin film morphology was analyzed by scanning electron microscope (SEM). Highly ordered α-TiOPc film with an edge-on molecular orientation was deposited on octadecyltrichlorosilane (OTS) treated Si/SiO 2 surface. All TiOPc crystal forms, such as amorphous, α and γ phases, provided the triclinic phase II crystal of TiOPc. The full width at half maximum (FWHM) of the peak at 7.5 degree in XRD spectra was 0.23, 0.27 and 0.29 for γ, α and amorphous powder when substrate temperature maintained at 180°C, respectively. The FWHM of the 7.5 degree peak can be achieved 0.22 deposited from all crystal forms at elevated temperature higher than 220°C. The α-TiOPc deposition film exhibited an excellent p-type semiconducting behavior in air with dense packing structure due to the close π-π molecular packing. The devices, field-effect mobility range from 0.02 to 0.26 cm 2 /V s depending on various process parameters. The on/off current ratio (I on /I off ) is over 10 5 . The TiOPc OTFTs will be applied as multi-parameter gas sensor in the near future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.